Startseite ÖGU

IMI2 – Preparing for the 13th Call

The Innovative Medicines Initiative 2 (IMI 2) is scheduled to open its 13th call on November 30th, 2017. Planned topics include: diabetic cardiomyopathy; neurodegenerative diseases; tumour microenvironment immunoprofiling; inflammatory skin diseases; pluripotent stem cell platform; digital assessment of mobility; novel safety biomarkers; preclinical prediction of adverse effects; clinical compound bank.
Expected Deadline for short applications (1st stage, 30 pages): February 28th, 2018

Webinars: From November 27th to December 15th IMI will hold a free webinar for each topic, regarding rules for participation, funding conditions and IPR. There will also be opportunities to get in contact with topic coordinators and potential partners.

» Registration (mandatory): http://www.imi.europa.eu/news-events/events/webinars-imi2-call-13
» Preliminary call texts: http://www.imi.europa.eu/content/future-topics
» Partner search tool: http://www.imi.europa.eu/content/partner-search

If you consider a participation, please contact the European Office (see below)!

Please, contact us for a personal appointment!

Research Service / National Funding Programmes:
Mag.a Astrid Pils, T: +43 (1) 40160-25205, astrid.pils@meduniwien.ac.at

Research Service / European Office:
Mag.a Susanne Friedl, T: +43 (1) 40160-25222, susanne.k.friedl@meduniwien.ac.at
DIin Iris Weinbub, T: +43 (1) 40160-25224, iris.weinbub@meduniwien.ac.at
europabuero@meduniwien.ac.at

Entschuldigung, Kommentare zu diesem Artikel sind nicht möglich.